Clinical trial
Phase I In-vivo Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus
NCT03589443 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I In-vivo Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus
- Lead sponsor
- University of Michigan
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 10, 2018
- Completion date
- February 4, 2019
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.